LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Search

Twist Bioscience Corp

Closed

SectorHealthcare

30.82 -3.99

Overview

Share price change

24h

Current

Min

30.59

Max

31.17

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

3.2M

-21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+22.86% upside

Market Stats

By TradingEconomics

Market Cap

101M

2B

Previous open

34.81

Previous close

30.82

News Sentiment

By Acuity

50%

50%

167 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

12 Dec 2025, 16:42 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

12 Dec 2025, 23:49 UTC

Acquisitions, Mergers, Takeovers

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 Dec 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 Dec 2025, 22:32 UTC

Earnings

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Dec 2025, 20:45 UTC

Earnings

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 Dec 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 Dec 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 Dec 2025, 19:23 UTC

Earnings

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 Dec 2025, 18:35 UTC

Acquisitions, Mergers, Takeovers

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 Dec 2025, 18:33 UTC

Acquisitions, Mergers, Takeovers

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 Dec 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 Dec 2025, 17:49 UTC

Earnings

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 Dec 2025, 17:34 UTC

Acquisitions, Mergers, Takeovers

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

12 Dec 2025, 17:33 UTC

Acquisitions, Mergers, Takeovers

Orange: Closing of the Transaction Is Expected in the First Half of 2026

12 Dec 2025, 17:33 UTC

Acquisitions, Mergers, Takeovers

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

12 Dec 2025, 17:32 UTC

Acquisitions, Mergers, Takeovers

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

12 Dec 2025, 17:31 UTC

Acquisitions, Mergers, Takeovers

Orange to Buy the Stake for EU4.25B in Cash

12 Dec 2025, 17:24 UTC

Market Talk

Argentina Predicts Record Wheat Crop -- Market Talk

12 Dec 2025, 17:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 Dec 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Dec 2025, 17:18 UTC

Market Talk
Earnings

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

12 Dec 2025, 17:09 UTC

Market Talk

Broadcom Investors Were Primed to Sell Shares -- Market Talk

12 Dec 2025, 17:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Dec 2025, 16:47 UTC

Market Talk

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

12 Dec 2025, 16:39 UTC

Market Talk

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

12 Dec 2025, 16:27 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Deal for Liquid Nails From PE Firm -- 2nd Update

12 Dec 2025, 16:15 UTC

Earnings

At Costco, Lots of Pie but No Special Dividend. Why the Street Didn't Like the Earnings. -- Barrons.com

12 Dec 2025, 15:35 UTC

Earnings

These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 Dec 2025, 14:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

22.86% upside

12 Months Forecast

Average 38 USD  22.86%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

167 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat